Safety and efficacy of non-medical switching from originator infliximab to infliximab biosimilar CT-P13 in patients with inflammatory bowel disease
Not Applicable
- Conditions
- Crohn's disease, Ulcerative colitis, IBD
- Registration Number
- JPRN-UMIN000043165
- Lead Sponsor
- Fukuoka University Chikushi Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 220
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients who don't consent 2. Patients who are judged not suitable for this trial by the doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method